Related Experiment Video
Updated: Apr 26, 2026
05:23
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
18.8K
The pathophysiology of transfusional iron overload
John B Porter1, Maciej Garbowski1
1Department of Haematology, University College London, 72 Huntley Street, London WC1E 6BT, UK.
Hematology/Oncology Clinics of North America
|July 28, 2014
Summary
Transfusional iron overload (TIO) causes organ damage and infection risk. Iron chelation therapy offers benefits, with iron distribution influenced by red cell breakdown and iron utilization by the erythron.
Area of Science:
- Hematology
- Toxicology
- Pharmacology
Background:
- Transfusional iron overload (TIO) is a complication of chronic blood transfusions.
- While well-studied in thalassemia major, TIO is increasingly recognized in other conditions.
- Excess iron accumulation impacts the heart, liver, and endocrine organs, leading to significant pathology.
Purpose of the Study:
- To describe the pathophysiologic consequences of TIO.
- To highlight the benefits of iron chelation therapy in managing TIO.
- To explore factors influencing iron distribution and toxicity outside the liver.
Main Methods:
- Review of existing literature on TIO and iron chelation therapy.
- Analysis of pathophysiologic mechanisms of iron toxicity.
- Discussion of iron metabolism and distribution dynamics.
Main Results:
- TIO leads to iron deposition in vital organs, causing damage.
- Iron overload increases susceptibility to infections due to labile iron availability.
- Extrahepatic iron distribution is influenced by the balance between iron generation and erythron utilization.
Conclusions:
- Understanding TIO pathophysiology is crucial for patient management.
- Iron chelation therapy is essential for mitigating TIO complications.
- Further research into iron distribution mechanisms can inform treatment strategies.
Related Concept Videos
01:28The Early Endosome: Endocytosis of Transferrin
4.0K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
4.0K
01:24Cirrhosis II: Pathophysiology
33
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
33
01:27Disorders of Erythrocytes
2.6K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.6K
02:45Blood Transfusion and Agglutination
12.7K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
12.7K
01:22Portal Hypertension
30
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
30
01:22Lifecycle of Erythrocytes
5.6K
Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
5.6K